Table 1.
Distribution of baseline variables according to the Dtotal groups
| Baseline variable | Dtotal < 50 nmol/L | Dtotal ≥ 50 nmol/L |
|---|---|---|
| Age (years), mean | ||
| Gender; female, n (%) | ||
| Disease duration before diagnosis (months), mean | ||
| Ciclosporin treatment, n (%) | ||
| Smoking status (ever), n (%) | ||
| Blood pressure (mm Hg), mean | ||
| BMI (kg/m2), mean | ||
| CRP (mg/L), mean | ||
| IgM RF positive, n (%) | ||
| ACPA positive, n (%) | ||
| NSJ, mean | ||
| NTJ, mean | ||
| Known CVD at baseline, n (%) | ||
| NSAID use (ever), n (%) | ||
| Antihypertensive treatment after inclusion, n (%) | ||
| Statin treatment after inclusion, n (%) | ||
| Time lost to follow-up (person-years) |
ACPA, anticitrullinated peptide antibodies; BMI, body mass index; CRP, C reactive protein; CVD, cardiovascular disease; IgM RF, IgM-rheumatoid factor; NSAID, non-steroidal anti-inflammatory drug; NSJ, number of swollen joints; NTJ, number of tender joints.